Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Crucell Resolves Issues at South Korea Plant | Contract Pharma

What are you searching for?

Sign in
Breaking News

Crucell Resolves Issues at South Korea Plant

Crucell NV can resume selling its vaccine Quinvaxem to United Nations agencies, after investigations by the World Health Organization showed the manufacturing problems at Crucell’s plant in South Korea were resolved.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Crucell NV can resume selling its vaccine Quinvaxem to United Nations agencies, after investigations by the World Health Organization showed the manufacturing problems at Crucell’s plant in South Korea were resolved. Crucell suspended production due to sterility issues at the plant and stopped shipments of two children’s vaccines, including Quinvaxem.

The manufacturing problems resulted in a loss for the company in 2010 and put on hold Johnson & Johnson’s $2.4 billion bid to takeover the company. J&J’s bid expires February 16th; the company currently holds about 18% of Crucell shares.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters